Skip to content
University of Washington Drug Interaction Solutions School of Pharmacy
  •  
  • About Us
    • What we do
    • How we work
    • Our team
    • History
    • Linked
  • Our Solutions
    • DIDB – The Drug Interaction Database
    •   Human in vitro datasets
    •   Clinical datasets
    • Custom solutions
    • Testimonials
  • Subscription
    • Licensing
    • Account policies
    • Terms and conditions of use
    • Privacy statement
  • News
  • Support
  • Contact us
  • Sign in
  • DIDB
September 16, 2022 |  News

Data Curation and Entry in DIDB – August Summary

In August, we added 104 citations in DIDB, including 39 in vitro (with 22 articles published in August 2022) and 65 in vivo articles (with 37 articles published in August 2022).

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.

Post navigation

New features! Drug Characteristics queries expanded, and Invite a colleague to use DIDB
Enzyme- and Transporter-Mediated Clinical Drug Interactions with Drugs by the U.S. Food and Drug Administration in 2021: What Can be Learned from New Drug applications Reviews?
Follow us on Linked

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications

Recent News

  • Data Curation and Entry in DIDB – December Summary
  • DDI Marker Studies Knowledgebase – quarterly update
  • Video Tutorials – Increased Visibility
  • Data Curation and Entry in DIDB – November Summary
  • Data Curation and Entry in DIDB – October Summary

Brochures

  • Why us?
  • Human in vitro drug metabolism
  • Human in vitro drug transporter
  • Clinical drug interaction
  • Clinical organ impairment
  • Clinical pharmacogenetics

Have you created your account yet?

Create your account now Already have an account? Sign in.
Want to know if your organization has a license to access UW DIDB?
Contact us
Copyright © 2005-2023 University of Washington | Seattle, WA. All Rights Reserved.